Complementary pre-screening strategies to uncover hidden prodromal and mild Alzheimer's disease: Results from the MOPEAD project.

Autor: Boada M; Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Barcelona, Spain., Rodrigo A; GMV SECURE E SOLUTIONS, Valencia, Spain., Jessen F; Department of Psychiatry, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.; Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine and University Hospital Cologne, Cologne, Germany., Wimblad B; Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, Sweden.; Theme Aging, Karolinska Univ Hospital, Stockholm, Sweden., Kramberger MG; Department of Neurology, University Medical Center Ljubljana and Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia., Visser PJ; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands., Simó R; Institut de Recerca Vall d'Hebron, Universitat Autònoma de Barcelona (VHIR-UAB), Barcelona, Spain.; CIBER de Diabetes y Enfermedades Metabólicas Asociadas. Instituto de Salud Carlos III, Spain., Rodríguez-Gomez O; Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya, Barcelona, Spain., Ciudin A; Institut de Recerca Vall d'Hebron, Universitat Autònoma de Barcelona (VHIR-UAB), Barcelona, Spain.; CIBER de Diabetes y Enfermedades Metabólicas Asociadas. Instituto de Salud Carlos III, Spain., Georges J; Alzheimer Europe, Luxembourg., Dumas A; ASDM Consulting, Brussels, Belgium., Maguire P; European Institute of Women's Health, Dublin, Ireland., Krivec D; Zdruzenje Spomincica, Ljubljana, Slovenia., Wimo A; Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, Sweden., Valero S; Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Barcelona, Spain., Alegret M; Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades - Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Barcelona, Spain., Jamilis L; GMV SECURE E SOLUTIONS, Valencia, Spain., Zwan M; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands., Sannemann L; Department of Psychiatry, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany., Arrufat J; EAP Sarrià-Vallvidrera-Les Planes, Barcelona, Spain., Stomrud E; Clinical Memory Research Unit, Lund University, Malmö, Sweden.; Emmaboda Health Centre, Region Kalmar County, Emmaboda, Sweden., Johansson G; Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, Sweden., Shering C; AstraZeneca, Waltham, Massachusetts, USA., Glaysher B; Modus Research and Innovation Limited, Dundee, Scotland., Stewart N; Modus Research and Innovation Limited, Dundee, Scotland., Belger M; Eli Lilly and Company (Lilly UK), Surrey, UK., Iradier F; Eli Lilly and Company, Spain., Campo L; Eli Lilly and Company, Firenze, Italy.

Publikováno v: Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2022 Jun; Vol. 18 (6), pp. 1119-1127. Date of Electronic Publication: 2021 Jul 26.

A Cost-Consequence Analysis of Different Screening Procedures in Alzheimer's Disease: Results from the MOPEAD Project.

Autor: Wimo A; Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet, Solna, Sweden., Belger M; Eli Lilly and Company Ltd (ELI), Bracknell, UK., Bon J; University Medical Centre Ljubljana (UMCL), Ljubljana, Slovenia., Jessen F; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Psychiatry, Cologne, Germany.; Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) Universität zu Köln, Köln, Germany.; Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Germany., Dumas A; ASDM Consulting, EU Affairs Director, Brussels, Belgium., Kramberger MG; Department of Neurology, University Medical Center Ljubljana and Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia., Jamilis L; GMV Soluciones Globales Internet S.A.U. (GMV), Spain., Johansson G; Department of Neurobiology, Care sciences and Society, Division of Neurogeriatrics, Karolinska Institutet, Solna, Sweden., Rodrigo Salas A; GMV Soluciones Globales Internet S.A.U. (GMV), Spain., Rodríguez Gómez O; Fundació ACE (FACE), Barcelona, Spain., Sannemann L; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Psychiatry, Cologne, Germany., Stoekenbroek M; Amsterdam UMC, VU University, Amsterdam, Amsterdam, the Netherlands., Gurruchaga Telleria M; Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades, Universitat Internacional de Catalunya, Barcelona, Spain., Valero S; Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades, Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain., Vermunt L; Amsterdam UMC, VU University, Amsterdam, Amsterdam, the Netherlands., Waterink L; Amsterdam UMC, VU University, Amsterdam, Amsterdam, the Netherlands., Winblad B; Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet, Solna, Sweden.; Karolinska University Hospital, Theme Inflammation and Aging, Huddinge, Sweden., Visser PJ; Amsterdam UMC, VU University, Amsterdam, Amsterdam, the Netherlands., Zwan M; Amsterdam UMC, VU University, Amsterdam, Amsterdam, the Netherlands., Boada M; Fundació ACE (FACE), Barcelona, Spain.; Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades, Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.

Publikováno v: Journal of Alzheimer's disease : JAD [J Alzheimers Dis] 2021; Vol. 83 (3), pp. 1149-1159.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Cognitive Profile and Cardiovascular Risk Factors in Older Adults with Mild Cognitive Impairment.

Autor: Vázquez-de Sebastián, Julia, Ortiz-Zuñiga, Angel M., Ciudin, Andreea, Ars, Joan, Inzitari, Marco, Simó, Rafael, Hernández, Cristina, Ariño-Blasco, Sergio, Barahona, María José, Franco, Maite, Gironès, Xavier, Crespo-Maraver, María Cruz, Rovira, Joan Carles, Castellano-Tejedor, Carmina

Publikováno v: International Journal of Environmental Research & Public Health; Apr2024, Vol. 21 Issue 4, p500, 15p

A Literature Review on the Burden of Alzheimer's Disease on Care Partners.

Autor: Frederiksen, Kristian Steen, Lanctôt, Krista L., Weidner, Wendy, Hahn-Pedersen, Julie Hviid, Mattke, Soeren

Publikováno v: Journal of Alzheimer's Disease; 2023, Vol. 96 Issue 3, p947-966, 20p